| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jan 25 | AKTX Akari Therapeutics | Ordinary Shares, par value $0.0001 per share | Grant | Acquire A | No | No | 0.0006 | 8,000,000 | 4.80 k | 32,216,000 |
| 23 Dec 24 | AKTX Akari Therapeutics | Ordinary Shares, par value $0.0001 per share | Grant | Acquire A | No | No | 0.0005 | 2,000,000 | 1.00 k | 24,216,000 |
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Sale back to company | Dispose D | No | No | 0 | 37,850 | 0.00 | 0 |
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Conversion | Acquire C | No | No | 0 | 37,850 | 0.00 | 37,850 |
| 14 Nov 24 | PKBO Peak Bio | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.8 | 500,000 | 400.00 k | 0 |
| 14 Nov 24 | PKBO Peak Bio | Warrant (Right to Purchase) Common Stock | Sale back to company | Dispose D | No | No | 0.6 | 33,340 | 20.00 k | 0 |
| 3 Sep 24 | PCSA Processa Pharmaceuticals | Restricted Stock Common Stock | Grant | Acquire A | No | No | 0 | 31,206 | 0.00 | 31,206 |
